CLDI Total Utang marang Modal Calidi Biotherapeutics

CLDI (Calidi Biotherapeutics) - tandha merek perusahaan

Calidi Biotherapeutics brings together leading cell biologists to develop breakthrough stem cell-based platforms. The continuity of clinical trials is ensured by a strict temperature regime during drug transportation. This chart of the separate_debt_total_eq metric at the 0.66 level complements the picture of a business operating amidst a fierce struggle for capital against immunotherapy behemoths.

Rasio Utang marang Ekuitas: Calidi Biotherapeutics Inc. (CLDI) kanggo 21.02.2024 - 28.10.2026

Rincian metrik komprehensif lan analitis Calidi Biotherapeutics, Inc. (CLDI)

- rega lan prakiraan konsensus rega:
Rega saham Calidi Biotherapeutics Inc.|CLDI - Target konsensus
- data kapitalisasi pasar:
Kapitalisasi pasar Calidi Biotherapeutics|CLDI - Nilai Perusahaan
- data kapitalisasi buku:
Aset Bersih saben Siji Saham Calidi Biotherapeutics|CLDI - Kapitalisasi Akuntansi|Rasio Kapitalisasi Pasar marang Nilai Buku calidibio.com|CLDI - Gunggung Aset Perusahaan
- data utang lan likuiditas:
Total Utang marang Modal Calidi Biotherapeutics|CLDI - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas Calidi Biotherapeutics Inc.|CLDI - Kewajiban utang agregat|Utang marang nilai buku Calidi Biotherapeutics|CLDI - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Calidi Biotherapeutics
Analisis komprehensif perusahaan:CLDI - Calidi Biotherapeutics
Sampel barang Calidi Biotherapeutics Inc.

Calidi Biotherapeutics' unique patent solutions in the field of oncolytic platforms create a significant barrier to entry for competitors, providing the company with a technological advantage. An analysis of the total debt-to-equity ratio allows for an assessment of the proportion of borrowed funds relative to equity, which determines the issuer's financial autonomy and the resilience of its share price to potential default risks should borrowing costs change.

Pesaing utama

Total Utang marang Modal ONC|Rasio Total Utang marang Ekuitas Halozyme Therapeutics, Inc.|Total Utang marang Modal RVMD|Total Utang marang Modal AAPG (Ascentage Pharma Corp)|CGON - Utang marang Ekuitas|Rasio Utang marang Ekuitas urogen.com URGN|BCAX: Total Utang marang Modal|PSNL - Rasio Total Utang marang Ekuitas|Total Utang marang Modal ERAS|DCTH (Delcath Corp) - Utang marang Modal|YMAB - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi aurabiosciences.com (AURA)|Candel Therapeutics (CADL) - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi Accuray Inc (ARAY)|SELLAS Life Sciences Group - Total Utang marang Modal|ACTU - Rasio Total Utang marang Ekuitas|Citius Oncology, Inc. - Rasio Total Utang marang Ekuitas|HURA: Total Utang marang Modal|Utang marang Ekuitas Protara Therapeutics, Inc. TARA|Fate Therapeutics Inc (FATE) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal WHWK (Aadi Bioscience, Inc.)|Utang marang Modal TScan|Total Utang marang Modal CSBR (Champions Oncology)|Rasio Total Utang marang Ekuitas xbiotech.com (XBIT)|Total Utang marang Modal CVM (CEL-SCI)|OS Therapies Inc. - Total Utang marang Modal|RADX - Utang marang Ekuitas|ARTV - Utang marang Ekuitas|adlainortye.com - Total Utang marang Modal|verupharma.com (VERU) - Koefisien Total Utang marang Modal|Total Utang marang Modal Tempest Therapeutics, Inc. (TPST)|Rasio Utang marang Ekuitas Xilio|RENB (Renovaro Inc.) - Total Utang marang Modal|Koefisien Total Utang marang Modal muraloncology.com MURA|Rasio Total Utang marang Ekuitas Kairos Pharma|Rasio Kabeh Utang marang Dana Pribadi OnKure Therapeutics, Inc. OKUR|GDTC - Total Utang marang Modal|CRIS - Utang marang Ekuitas|apollomicsinc.com - Total Utang marang Modal|THAR (Tharimmune Corporation) - Koefisien Total Utang marang Modal|Utang marang Ekuitas ADVB (Advanced Biomed Inc.)|Utang marang Modal genprex.com (GNPX)|Rasio Total Utang marang Ekuitas Sunshine Biopharma, Inc.|Utang Agregat marang Modal xeneticbio.com (XBIO)|Total Utang marang Modal Salarius|Rasio Kabeh Utang marang Dana Pribadi Kitov Pharma PPBT|AONC (AON) - Total Utang marang Modal|BGNE: Utang marang Modal|Utang marang Ekuitas Checkpoint Therapeutics, Inc. CKPT|elevationoncology.com (ELEV) - Rasio Kabeh Utang marang Dana Pribadi|ICAD (iCAD Inc.) - Total Utang marang Modal|Total Utang marang Modal IKNA|NTBL - Utang marang Ekuitas|Utang Agregat marang Ekuitas viracta.com (VIRX)|MOR: Total Utang marang Modal|NAYA - Utang marang Modal|Ascentage Pharma Group Ltd - Rasio Total Utang marang Ekuitas